The Pennant Group (PNTG) Competitors $23.76 -0.70 (-2.86%) Closing price 04:00 PM EasternExtended Trading$23.76 0.00 (0.00%) As of 05:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PNTG vs. SHC, SGRY, PRVA, CON, WGS, VCYT, ADUS, PACS, ARDT, and LFSTShould you be buying The Pennant Group stock or one of its competitors? The main competitors of The Pennant Group include Sotera Health (SHC), Surgery Partners (SGRY), Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), GeneDx (WGS), Veracyte (VCYT), Addus HomeCare (ADUS), PACS Group (PACS), Ardent Health (ARDT), and LifeStance Health Group (LFST). These companies are all part of the "healthcare" industry. The Pennant Group vs. Its Competitors Sotera Health Surgery Partners Privia Health Group Concentra Group Holdings Parent GeneDx Veracyte Addus HomeCare PACS Group Ardent Health LifeStance Health Group The Pennant Group (NASDAQ:PNTG) and Sotera Health (NASDAQ:SHC) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, media sentiment, valuation, profitability and risk. Which has more risk and volatility, PNTG or SHC? The Pennant Group has a beta of 1.51, meaning that its share price is 51% more volatile than the S&P 500. Comparatively, Sotera Health has a beta of 1.81, meaning that its share price is 81% more volatile than the S&P 500. Does the media favor PNTG or SHC? In the previous week, The Pennant Group had 2 more articles in the media than Sotera Health. MarketBeat recorded 5 mentions for The Pennant Group and 3 mentions for Sotera Health. Sotera Health's average media sentiment score of 1.77 beat The Pennant Group's score of 1.16 indicating that Sotera Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment The Pennant Group 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Sotera Health 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Which has higher valuation & earnings, PNTG or SHC? Sotera Health has higher revenue and earnings than The Pennant Group. The Pennant Group is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioThe Pennant Group$695.24M1.18$22.56M$0.7631.26Sotera Health$1.10B2.90$44.34M$0.08140.38 Do analysts prefer PNTG or SHC? The Pennant Group currently has a consensus price target of $33.80, indicating a potential upside of 42.26%. Sotera Health has a consensus price target of $16.00, indicating a potential upside of 42.48%. Given Sotera Health's stronger consensus rating and higher probable upside, analysts plainly believe Sotera Health is more favorable than The Pennant Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score The Pennant Group 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60Sotera Health 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80 Is PNTG or SHC more profitable? The Pennant Group has a net margin of 3.40% compared to Sotera Health's net margin of 2.24%. Sotera Health's return on equity of 41.08% beat The Pennant Group's return on equity.Company Net Margins Return on Equity Return on Assets The Pennant Group3.40% 10.73% 4.00% Sotera Health 2.24%41.08%5.68% Do institutionals and insiders believe in PNTG or SHC? 85.9% of The Pennant Group shares are held by institutional investors. Comparatively, 91.0% of Sotera Health shares are held by institutional investors. 5.4% of The Pennant Group shares are held by company insiders. Comparatively, 47.6% of Sotera Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. SummarySotera Health beats The Pennant Group on 13 of the 16 factors compared between the two stocks. Get The Pennant Group News Delivered to You Automatically Sign up to receive the latest news and ratings for PNTG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PNTG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PNTG vs. The Competition Export to ExcelMetricThe Pennant GroupMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$843.11M$3.74B$5.52B$9.32BDividend YieldN/A1.36%4.25%4.05%P/E Ratio31.2634.9928.1519.68Price / Sales1.1898.31438.33100.29Price / Cash26.5322.5035.5357.53Price / Book2.624.278.235.67Net Income$22.56M$189.47M$3.23B$257.51M7 Day Performance-9.17%-2.09%-0.01%0.52%1 Month Performance-16.57%-7.12%5.61%8.84%1 Year Performance-13.25%-4.77%26.52%14.18% The Pennant Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PNTGThe Pennant Group3.6545 of 5 stars$23.76-2.9%$33.80+42.3%-6.8%$843.11M$695.24M31.267,000News CoveragePositive NewsAnalyst ForecastSHCSotera Health3.1975 of 5 stars$11.40-2.9%$16.00+40.4%-6.9%$3.33B$1.10B142.523,000News CoveragePositive NewsSGRYSurgery Partners2.5004 of 5 stars$22.03-0.5%$33.56+52.3%-15.2%$2.84B$3.11B-14.4015,000PRVAPrivia Health Group3.8176 of 5 stars$21.35-3.4%$27.77+30.1%+14.9%$2.70B$1.74B177.931,140CONConcentra Group Holdings Parent2.8287 of 5 stars$20.33-1.1%$28.50+40.2%N/A$2.64B$1.90B15.1711,250WGSGeneDx3.7809 of 5 stars$85.74-6.4%$90.13+5.1%+136.8%$2.61B$330.14M-60.811,200Analyst DowngradeVCYTVeracyte3.566 of 5 stars$26.34-4.3%$40.90+55.3%+11.7%$2.15B$445.76M64.25790News CoveragePositive NewsADUSAddus HomeCare4.9686 of 5 stars$110.62-1.1%$142.57+28.9%-9.1%$2.06B$1.15B24.9749,703Positive NewsAnalyst ForecastPACSPACS Group2.7562 of 5 stars$12.51-4.8%$34.29+174.1%-60.7%$2.00B$3.11B0.0032,433ARDTArdent Health3.3578 of 5 stars$13.34-0.4%$20.67+54.9%N/A$1.92B$5.97B8.1824,900News CoverageAnalyst DowngradeGap DownLFSTLifeStance Health Group2.9958 of 5 stars$4.68-2.3%$8.50+81.6%-19.7%$1.86B$1.25B-46.8010,218 Related Companies and Tools Related Companies SHC Competitors SGRY Competitors PRVA Competitors CON Competitors WGS Competitors VCYT Competitors ADUS Competitors PACS Competitors ARDT Competitors LFST Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PNTG) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredIs this secretive Asian company trying to take over Bitcoin?A mysterious Asian conglomerate is buying billions in Bitcoin — but one legendary trader says that’s the wrong...Brownstone Research | SponsoredNvidia’s next AI move could catch traders flat-footedTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredTrump has to finance $21 trillion. Here’s His Move…Trump needs $21 trillion to fund his agenda — and insiders believe he’s quietly preparing a major shift in the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Pennant Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share The Pennant Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
